About Palette Life Sciences
Palette Life Sciences is a company based in Stockholm (Sweden) founded in 2016 was acquired by Teleflex Medical in July 2023. Palette Life Sciences has raised $30 million across 3 funding rounds from investors including SVB, Teleflex Medical and Orbimed. Palette Life Sciences offers products and services including Barrigel and Deflux.
- Headquarter Stockholm, Sweden
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Palette Life Sciences, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$30 M (USD)
in 3 rounds
-
Latest Funding Round
-
Investors
SVB
& 3 more
-
Employee Count
Employee Count
-
Acquired by
Teleflex Medical
(Jul 26, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Palette Life Sciences
Palette Life Sciences offers a comprehensive portfolio of products and services, including Barrigel and Deflux.
Barrigel is utilized in medical applications as a trademark that was acquired by Teleflex
Deflux is employed in urological treatments and is recognized as a trademark under Teleflex
People of Palette Life Sciences
Unlock access to complete
Unlock access to complete
Funding Insights of Palette Life Sciences
Palette Life Sciences has successfully raised a total of $30M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
-
First Round
First Round
(21 Oct 2021)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2023 | Amount | Debt – Conventional - Palette Life Sciences | Valuation |
investors |
|
| Oct, 2021 | Amount | Debt – Conventional - Palette Life Sciences | Valuation |
investors |
|
| Oct, 2021 | Amount | Series B - Palette Life Sciences | Valuation | Schörling |
|
Investors in Palette Life Sciences
Palette Life Sciences has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Teleflex Medical and Orbimed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Banking services are provided to innovative companies, investors, and individuals.
|
Founded Year | Domain | Location | |
|
Business consulting services are provided by Schörling in Sweden.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Palette Life Sciences
Financial Statements - Palette Life Sciences
Palette Life Sciences Comparisons
Competitors of Palette Life Sciences
Latest news on Palette Life Sciences
Frequently Asked Questions about Palette Life Sciences
Palette Life Sciences was founded in 2016 and raised its 1st funding round 5 years after it was founded.
Palette Life Sciences is headquartered in Stockholm, Sweden.
Palette Life Sciences is a funded company, having raised a total of $30M across 3 funding rounds to date. The company's 1st funding round was a Series B of $30M, raised on Oct 21, 2021.
Palette Life Sciences was founded in 2016 and is based in Stockholm, Sweden. Operations center on the production of generic finished formulations within the pharmaceutical sector. Key products include Deflux for vesicoureteral reflux, Solesta for fecal incontinence, Barrigel for rectal wall protection during radiotherapy, and Lidbree. Focus areas encompass urology, urogynecology disorders, colorectal conditions, and interventional oncology procedures.
Palette Life Sciences offers Barrigel and Deflux.
Palette Life Sciences has 4 investors. Key investors include SVB, Teleflex Medical, Orbimed, and Schörling.